$SFIX

Bacos Anthony sold $290K of SFIX

Bacos Anthony (Chief Prod/Technology Officer) sold 70,000 shares of Stitch Fix, Inc. (SFIX) at an average of $4.15 ($4.14–$4.17, $0.29M total) across 2 trades on 2026-06-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bacos Anthony
Published Jun 18, 2026, 6:43 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 6:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SFIX
Neutral
medium confidence
Mentioned
$SFIX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SFIXNeutralLow
01

Why it matters

The disclosed sale confirms an officer’s planned liquidity event; absent any new operational or financial disclosures, it is unlikely to change valuation drivers.

02

Market read

Useful for tracking insider activity, but not a standalone fundamental catalyst.

03

What to watch

Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or operating metrics, the filing is unlikely to drive repricing.

Relevance 3/10Novelty 5/10Timing: today’s SEC Form 4 filing (filed 2026-06-18)

Background

The article is an SEC Form 4 insider transaction disclosure for Stitch Fix, Inc. (SFIX).

Company-level read

Ticker impact

$SFIXNeutralMedium confidence
Context

SEC Form 4 shows officer Bacos Anthony sold 70,000 shares of Stitch Fix at ~$4.1454 via a 10b5-1 plan filed June 18.

Expected impact

Likely minimal near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is a disclosed open-market sale by a named officer with a pre-arranged 10b5-1 plan; insider sales of this type are typically not a standalone catalyst for earnings or guidance changes.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None.

None.

Counterpoint

Because the sale is explicitly under a 10b5-1 plan, it may be mechanically scheduled and not informative about near-term business outlook.

Key entities

  • Stitch Fix, Inc.

    Subject of the Form 4 insider sale disclosure; officer sale under a 10b5-1 plan.

  • Bacos Anthony

    Chief Product/Technology Officer who sold 70,000 shares across two trades.

Related articles

$SFIXMedAI 8/10

Why Stitch Fix Stock Surged Today

Stitch Fix shares rose 15.69% on Thursday after the company reported fiscal 2026 Q3 results that beat investor expectations. Revenue increased 4.7% to $340 million; net revenue per active client rose 6.6% to $578. Net loss narrowed to $1.5 million, free cash flow was $6.5 million, and adjusted EBITDA rose 20% to $13.2 million. Stitch Fix raised full-year guidance to about $1.35 billion revenue and $49–$52 million adjusted EBITDA, with positive free cash flow.

$ORCLMedAI 8/10

Futures Rise, Oil Drops As US Ends Iran Strikes

US equity futures rose as tech and small caps gained after US Central Command said strikes against Iran were complete, easing concerns about further escalation and the Strait of Hormuz reopening. S&P futures rose 0.7% and Nasdaq 100 1.1%; bond yields fell 1–3bp. Brent slipped ~1% below $92; WTI fell to $88.87. Oracle shares fell ~8% after higher-than-estimated capex; Navan jumped 19% after raising revenue outlook.